Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Jin Medical International Ltd.
Bear Case (25th pct.)
-78.4% vs price
Base Case (Median)
-67.8% vs price
Bull Case (75th pct.)
-60.8% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $0.22 | -88.7% | Medium (25%) |
| Graham Number | $0.92 | -53.6% | Medium (40%) |
| EV/EBITDA | $0.64 | -67.6% | Medium (20%) |
Based on 3 out of 7 methods, ZJYL appears overvalued at the current price of $1.99. The base case fair value of $0.64 implies 67.8% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.